EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $17,515 | +19.5% | 2,326 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $14,654 | -24.1% | 2,326 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $19,306 | -81.1% | 2,326 | -72.1% | 0.00% | -50.0% |
Q4 2020 | $102,314 | +51.0% | 8,325 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $67,766 | -15.2% | 8,325 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $79,920 | -33.4% | 8,325 | +3.4% | 0.00% | -50.0% |
Q4 2019 | $120,020 | +28.1% | 8,055 | -11.9% | 0.00% | 0.0% |
Q3 2019 | $93,675 | +343.4% | 9,139 | +358.6% | 0.00% | – |
Q2 2019 | $21,125 | – | 1,993 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
RA Capital Management | 354,200 | $4,056,000 | 0.50% |
DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |